Vaccination Rates Decline Worldwide
Vaccination rates have significantly decreased around the world from pre-COVID-19 pandemic levels, according to a 2023 immunization coverage report released by the World Health Organization (WHO) and UNICEF last month. The report, released on July 14, 2024, is the world’s most extensive dataset on vaccination trends targeting 14 diseases. This report analyzed estimates from 185 […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]
Congress Orders Research to Assess COVID Shot Injuries Among U.S. Military Personnel
In the National Defense Authorization Act (NDAA) for fiscal year 2024, the U.S. Congress is requiring the U.S. Department of Defense (DoD) to study and report on poor health conditions that active duty members of the Armed Forces developed after administration of COVID-19 shots.1 The NDAA was passed in late 2023 and calls for “a […]
U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 avian influenza biologic labeled a “vaccine,” as the media reports concerns about bird flu in dairy cows and farm workers in multiple states. The funds from the U.S. Biomedical Advanced Research and Development […]
More Parents in U.K. Refuse Childhood Vaccinations
In late 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that there had been a decline in state required vaccines from 95 percent to 93 percent among kindergarteners during the 2020-2021 school year compared to the 2019-2020 school year.1 2 Now, public health officials in the United Kingdom also are reporting lower […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]